StockData

MDxHealth vs Personalis

MDXH and PSNL side by side, both in health services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How MDXH and PSNL compare

MDxHealth grew revenue faster over the last twelve months (19.8% versus 16.9% for Personalis).

MDxHealth keeps more of each dollar of sales as profit, with a net margin of −31.1% compared with −148% at Personalis.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricMDXHPSNL
Size and price
Market cap–$1.7B
Share price$0.144$15.71
Change, 1 year−96.5%96.1%
Change, 5 years−98.6%5.1%
Beta (5Y)0.971.87
Employees364260
StockData Score
Total score55
Valuation score00
Growth score3 (better)0
Performance score1 (better)0
Health score15 (better)
Dividend score00
Valuation
P/S–20.8×
P/B–7.9×
FCF yield–−6.4%
Fair value–$3.28
Margin of safety–−379%
Growth
Revenue growth (TTM)19.8% (better)16.9%
Revenue growth, 5Y average42.3% (better)−2.4%
Profitability
Gross margin64.5% (better)16.7%
Operating margin−13.4% (better)−157%
Net margin−31.1% (better)−148%
FCF margin−3.1% (better)−133%
Return on equity–−62.1%
Return on invested capital–−465%
Financial health
Debt / equity–0.00
Interest coverage−0.6× (better)−684.0×
Current ratio1.084.53 (better)
Altman Z-score–8.83
Piotroski F-score34 (better)
Dividends and buybacks
Buyback yield–−8.0%
Shareholder yield–−8.0%
Ownership
Held by institutions32.3%79.6%
Held by insiders–15.0%
Insider net buying, 12 months$991K (better)−$6.9M
Short interest, % of float–7.4%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.